
Horizon Therapeutics Public Company Investor Relations Material
Latest events

Q3 2022
Horizon Therapeutics Public Company
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Horizon Therapeutics Public Limited Company
Access all reports
Segment Data
Access more data
Net sales by
Product
TEPEZZA
KRYSTEXXA
RAVICTI
PROCYSBI
Other
Expenses by
Financials
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. It markets IMMUNOCAL to physicians and healthcare professionals in the fields of pediatrics, rheumatology, orthopedics/spine, internal medicine/primary care, physical medicine and rehabilitation/pain management, neurology/neurosurgery, and sports medicine; and IMMUNOTEC to doctors and healthcare professionals in the field of gastroenterology. The company was formerly known as Horizon Pharma Plc and changed its name to Horizon Therapeutics Public Limited Company in April 2019
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
HZNP
Country
🇺🇸 United States